Junior Exploration Stock Jumps on Assay Results

Constantine Metal Resources Ltd. (CVE:CEM), a junior exploration stock, moved higher after announcing assay results from the Nunatak AG Zone in Alaska

Sean Mason | August 18, 2017 | SmallCapPower

‘Stone cold’ drill results attracted more than a few buyers to a junior exploration stock Friday. Here’s some small stocks making big moves on Friday, August 18, 2017 (as of 4 pm EST):

Constantine Metal Resources Ltd. (TSXV: CEM), a junior exploration stock, climbed 19% to $0.285 on Friday after announcing assay results for three additional drill holes from the Nunatak AG Zone, a new VMS discovery located 3 km from the known mineral resource at the Palmer Project in Alaska. Results included 461 g/t silver and 0.9 g/t gold over 10.3 meters, in addition to 11.3% zinc over 17.8 meters.

Win Big With Our Small Cap Picks

 

As well, shares of Absolute Software (TSX: ABT) slipped 7% to $7.46 as the company said its fiscal 2017 revenue rose 6% to US$91.2 million.

LED Medical Diagnostics Inc. (TSXV: LMD), meanwhile, reported a quarter-over-quarter revenue increase of 77% to US$3.7 million for Q2, while swinging to a profit of US$905,000 from a US$1.1 million loss during the same period last year. LED Medical Diagnostics stock moved up 22% to $0.055 following the announcement.

See more Small and Micro Cap Market Movers Daily from Sean Mason. Tomorrow’s big stock market winners could be found here today!

Hi, did you know SmallCapPower accepts blog submissions? You can contact me here

Disclosure: Neither the author nor any of the principals at Small Cap Power, or their family members, own shares in any of the companies mentioned above.

The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below: